Merck & Co

(Image: Getty/wildpixel)

Delays at MSD’s CMO prompt Sinemet shortage

By Flora Southey

MSD has warned regulators to expect a shortage of its Parkinson’s medicine, Sinemet, due to production constraints at a contract manufacturer’s facility.

US state backs pharma

US state backs pharma

The US state of North Carolina has launched a new initiative aimed
at encouraging investment in the pharmaceutical and biotechnology
industries, with sizeable grants available to companies prepared to
invest $100 million or more in...


Follow us


View more


Featured Suppliers